Dolby Laboratories, Inc. (NYSE:DLB) Major Shareholder Dagmar Dolby Sells 100,000 Shares

Share on StockTwits

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $65.27, for a total value of $6,527,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Friday, July 19th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.22, for a total value of $6,522,000.00.
  • On Friday, July 12th, Dagmar Dolby sold 22,069 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.02, for a total value of $1,434,926.38.
  • On Monday, July 15th, Dagmar Dolby sold 72,069 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.10, for a total transaction of $4,691,691.90.
  • On Friday, July 5th, Dagmar Dolby sold 26,358 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.01, for a total transaction of $1,713,533.58.
  • On Wednesday, July 3rd, Dagmar Dolby sold 77,692 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.17, for a total transaction of $5,063,187.64.
  • On Monday, July 1st, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.06, for a total transaction of $3,253,000.00.
  • On Thursday, June 27th, Dagmar Dolby sold 51,777 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.06, for a total transaction of $3,368,611.62.
  • On Tuesday, June 25th, Dagmar Dolby sold 15,617 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.04, for a total transaction of $1,015,729.68.
  • On Friday, June 21st, Dagmar Dolby sold 93,113 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.11, for a total transaction of $6,062,587.43.
  • On Wednesday, May 15th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $65.05, for a total transaction of $3,252,500.00.

NYSE DLB opened at $65.20 on Friday. The company’s 50-day simple moving average is $63.95. Dolby Laboratories, Inc. has a 12-month low of $58.17 and a 12-month high of $72.04. The stock has a market capitalization of $6.62 billion, a price-to-earnings ratio of 27.17, a price-to-earnings-growth ratio of 2.11 and a beta of 0.82.

Dolby Laboratories (NYSE:DLB) last posted its earnings results on Wednesday, May 1st. The electronics maker reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.18. The company had revenue of $338.26 million during the quarter, compared to analyst estimates of $337.45 million. Dolby Laboratories had a net margin of 24.93% and a return on equity of 11.12%. Dolby Laboratories’s revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.73 earnings per share. On average, equities research analysts forecast that Dolby Laboratories, Inc. will post 2.38 earnings per share for the current year.

DLB has been the subject of several analyst reports. B. Riley set a $18.00 price target on shares of TiVo and gave the company a “buy” rating in a research report on Thursday, June 13th. Zacks Investment Research lowered shares of Inflarx from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Finally, ValuEngine upgraded shares of Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st. Two research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $76.50.

Institutional investors have recently bought and sold shares of the company. First Quadrant L P CA boosted its holdings in shares of Dolby Laboratories by 1,476.3% during the first quarter. First Quadrant L P CA now owns 18,585 shares of the electronics maker’s stock worth $1,170,000 after purchasing an additional 17,406 shares during the period. First Trust Advisors LP purchased a new stake in shares of Dolby Laboratories during the fourth quarter worth about $715,000. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Dolby Laboratories during the first quarter worth about $616,000. Meeder Asset Management Inc. boosted its holdings in shares of Dolby Laboratories by 94.0% during the first quarter. Meeder Asset Management Inc. now owns 16,711 shares of the electronics maker’s stock worth $1,053,000 after purchasing an additional 8,099 shares during the period. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Dolby Laboratories by 4.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 543,749 shares of the electronics maker’s stock worth $33,623,000 after purchasing an additional 21,808 shares during the period. Institutional investors own 56.00% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.

Featured Story: Hedge Funds

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.